Oil-in-water emulsions for topical administration and uses thereof

Patent metadata

Field	Value
Publication number	US-2026083673-A1
Application number	US-202319113506-A
Country	US
Kind code	A1
Filing date	Sep 22, 2023
Priority date	Sep 23, 2022
Publication date	Mar 26, 2026
Grant date	—

Abstract

Oil-in-water Pickering emulsion comprising: an oil phase comprising a first therapeutic agent, an aqueous phase, polyester nanoparticles comprising a second therapeutic agent, wherein the oil phase is in the form of droplets and is dispersed in a continuous aqueous phase, and wherein at least a portion of the nanoparticles are localized at an interface between the oil phase and the aqueous phase, characterized in that the aqueous phase comprises hyaluronan. This new emulsion allows the topical treatment of inflammatory dermatoses such as psoriasis, atopic dermatitis or prurigo, benign skin inflammations such as inflammatory acne, scalp pathologies such asalopecia, dermo-cosmetic conditions, such as very dry irritable skin, tumor pathologies such as mycosis fungoides (indolent cutaneous T lymphoma) or cutaneous mastocytosis (accumulation and abnormal proliferation of mast cells in the dermis, with intense pruritus), and fibrosing pathologies such as keloids (raised, pruritic dystrophic scars, which have the particularity of not regressing spontaneously and of being able to extend beyond the traumatic/injured area).

First claim

1 . Oil-in-water Pickering emulsion comprising:
an oil phase comprising a first therapeutic agent, an aqueous phase, polyester nanoparticles comprising a second therapeutic agent,
wherein the oil phase is in the form of droplets and is dispersed in a continuous aqueous phase, and wherein at least a portion of the nanoparticles are localized at an interface between the oil phase and the aqueous phase,
and wherein the aqueous phase comprises hyaluronan.

2 . The oil-in-water Pickering emulsion according to claim 1 , wherein the pH of the emulsion is from 4.5 to 6.5.

3 . The oil-in-water Pickering emulsion according to claim 1 , wherein the oil phase comprises at least one oil chosen from fatty acids, fatty acid esters, vegetable oils, mineral oils, and mixtures thereof.

4 . The oil-in-water Pickering emulsion according to claim 3 , wherein the fatty acid esters are selected from triglycerides of medium-chain fatty acids.

5 . The oil-in-water Pickering emulsion according to claim 1 , wherein the droplets forming the oil phase have a size distribution ranging from 1 μm to 100 μm, as measured by dynamic light scattering.

6 . The oil-in-water Pickering emulsion according to claim 1 , wherein the polyester is selected from polylactic acid, polyglycolic acid, copolymers of lactic acid and glycolic acid, copolymers of lactic acid, glycolic acid and ethylene glycol, polyorthoesters, polyanhydrides, polylactones, polymalic acid, and mixtures thereof.

7 . The oil-in-water Pickering emulsion according to claim 6 , wherein the polyester is poly(lactic-co-glycolic acid).

8 . The oil-in-water Pickering emulsion according to claim 1 , wherein the first therapeutic agent is selected from anti-inflammatory agents and natural or semisynthetic analogs derived from metabolites of vitamin E.

9 . The oil-in-water Pickering emulsion according to claim 1 , wherein the second therapeutic agent is an immunosuppressive agent.

10 . The oil-in-water Pickering emulsion according to claim 1 , wherein the oil phase further comprises an antioxidant.

11 . The oil-in-water Pickering emulsion according to claim 1 , wherein the molar mass of hyaluronan is from 5000 g/mol to 5000000 g/mol.

12 . The oil-in-water Pickering emulsion according to claim 1 , wherein the concentration of hyaluronan in the aqueous phase calculated as the mass of hyaluronan in grams contained in 100 mL of the aqueous phase is from 0.15% to 5%.

13 . The oil-in-water Pickering emulsion according to claim 1 , wherein
the first therapeutic agent is Tacrolimus, and the second therapeutic agent is calcitriol.

14 . Pharmaceutical composition comprising the oil-in-water Pickering emulsion according to claim 1 and at least one pharmaceutically acceptable excipient.

15 . A method of treating a dermatologic pathology in a human or animal in need thereof, comprising administering to the human or animal a therapeutically effective amount of the oil-in-water Pickering emulsion of claim 1 .

Assignees

• Inst Nat Sante Rech Med
• Centre Nat Rech Scient
• Univ Paris Cite
• Univ Paris Saclay

Inventors

• Michel Laurence
• Sintès Maxime
• Albert Claire
• Agnely Florence
• Beladjine Mohamed Amine
• Huang Nicolas
• Tsapis Nicolas
• Haine Hablal Liasmine

Classifications

• A61K47/14

  Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title

• A61K31/728

  Hyaluronic acid · CPC title

• A61K31/593

  9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3 · CPC title

• A61K31/436

  the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin · CPC title

• A61K31/355

  Tocopherols, e.g. vitamin E · CPC title